Last reviewed · How we verify
Complicated Skin and Skin Structure Staphylococcus Aureus Infection
Approved treatments
- Tygacil · Fresenius Kabi
Tygacil works by binding to the 30S ribosomal subunit of bacteria, preventing the aminoacyl-tRNA from binding and thereby inhibiting protein synthesis. - Cubicin · Baxter
Daptomycin is an antibacterial drug with lipopeptide structure. - Avelox · Bayer AG
Fourth-generation fluoroquinolone with the broadest spectrum, covering gram-positive, gram-negative, anaerobic, and atypical organisms. - Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Tygacil · Pfizer
Tigecycline is a tetracycline class antibacterial agent. - Avelox · Novartis Pharmaceuticals
- Invanz · Merck & Co.
Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Vibativ · Cumberland
Vibativ works by binding to the bacterial cell wall, disrupting its synthesis and ultimately leading to cell death. - Synercid
- Zyvox · Pfizer
Zyvox works by inhibiting the bacterial protein synthesis initiation complex, preventing the growth and replication of Gram-positive bacteria. - Zosyn · Merck Sharp & Dohme B.V.
Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively. - Noroxin
- Floxin
- Vibativ · Cumberland
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Cubicin · Clinical Alliance for Research & Education - Infectious Diseases, LLC.
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
- DAPT · Baxter Hlthcare Corp
Dapt is a small molecule that works by interacting with specific biological targets, but the exact details of this interaction are unknown.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Complicated Skin and Skin Structure Staphylococcus Aureus Infection patent landscape — cliff calendar, originator estates, attackable patents
- Complicated Skin and Skin Structure Staphylococcus Aureus Infection treatment landscape brief
- Complicated Skin and Skin Structure Staphylococcus Aureus Infection treatment updates RSS
Frequently asked questions about Complicated Skin and Skin Structure Staphylococcus Aureus Infection
What drugs treat Complicated Skin and Skin Structure Staphylococcus Aureus Infection?
Tracked treatments include Tygacil, Cubicin, Avelox, Pipracil, Invanz, Vibativ, Synercid, Zyvox.
What is the treatment for Complicated Skin and Skin Structure Staphylococcus Aureus Infection?
Standard treatment for Complicated Skin and Skin Structure Staphylococcus Aureus Infection includes Tygacil, Cubicin, Avelox, Pipracil, Invanz. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Complicated Skin and Skin Structure Staphylococcus Aureus Infection patent cliff · Complicated Skin and Skin Structure Staphylococcus Aureus Infection CI report
- Treatment: Tygacil · Fresenius Kabi
- Treatment: Cubicin · Baxter
- Treatment: Avelox · Bayer AG
- Treatment: Pipracil
- Treatment: Tygacil · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing